TWST (Twist Bio) שולי הרווח הגולמי

Demand for synthetic DNA from pharmaceutical behemoths and the agricultural sector is driving growth for Twist Bioscience (TWST). Gross margin after deducting cost of sales demonstrates profitability dynamics, with the latest value recorded as 52.40. Business efficiency is powered by unique silicon synthesis, which reduces costs and enables the company to maintain pricing power while simultaneously cutting chemical waste by 99% as part of its ESG strategy.
פילוחי מדדים מקיפים ואנליטיקה עבור Twist Bio (TWST)

To assess the financial stability of Twist Bioscience (TWST), it is critical to track the monetization efficiency of its breakthrough silicon-based DNA synthesis technology. Gross margin measures the portion of revenue remaining after deducting direct production costs; therefore, gross margin stability confirms the company's ability to scale production while maintaining low costs, which determines the fundamental value of the business amid market volatility.